Organised, cytology-based cervical screening has led to a reduction in deaths associated
with cervical cancer. Human papillomavirus (HPV) is necessary for the development of …

The implementation of cytology-based screening programs for precancerous lesions of the
cervix has decreased the incidence of and mortality from cervical cancer in much of the …

Cervical cancer, caused by persistent cervical infection by high-risk HPV and made worse
by the HIV epidemic, remains an important cause of morbidity and mortality in South Africa …

Recent decades have witnessed a reduction in the incidence of cervical cancer in countries
where screening programmes have achieved broad coverage. The recognized importance …

Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Background This special section of Preventive Medicine is devoted to cervical cancer
screening. It covers why and how testing for human papillomavirus (HPV) is replacing …

Screening for cervical cancer precursors by cytology has been very successful in countries
where adequate resources exist to ensure high quality and good coverage of the population …

Several studies have examined the role of tests for human papillomavirus (HPV) in
screening for cervical cancer but as yet the relevance is unclear. We looked at HPV testing …